Crizotinib in ROS1 and MET Deregulated NSCLC-Response

Landi, L; Bruno, R; Fontanini, G; Cappuzzo, F

Cappuzzo, F (corresponding author), Azienda AUSL Romagna, Viale Randi 5, I-48121 Ravenna, Italy.

CLINICAL CANCER RESEARCH, 2020; 26 (7): 1775